BullishAgent BullishAgent Filings Market Economic Earnings Ratings Gaps IPOs ETFs Insiders Institutional Funds Screener
Sign in Register

NEUP

Neuphoria Therapeutics Inc. NASDAQ Listed Dec 16, 2021
Healthcare ·Medical - Pharmaceuticals ·US · neuphoriatx.com
$5.30
Mkt Cap $28.6M
52w Low $3.65 9.3% of range 52w High $21.40
50d MA $4.65 200d MA $6.62
P/E (TTM) -22.7x
EV/EBITDA 36.7x
P/B 0.3x
Debt/Equity 0.0x
ROE
P/FCF 0.1x
RSI (14)
ATR (14)
Beta 0.48
50d MA $4.65
200d MA $6.62
Avg Volume 47.3K
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.
CIK (SEC)
Phone
781-439-5551
100 Summit Dr · Burlington · US
Data updated apr 26, 2026 2:45pm · Source: massive.com